Please enable JavaScript to continue using this application.

Compare $LEGN vs $TNGX | Chartloom

Compare

$LEGN vs $TNGX

Legend Biotech Corp · Tango Therapeutics Inc

LEGN

Legend Biotech Corp

TNGX

Tango Therapeutics Inc

Compare $LEGN vs $TNGX

Comparing Legend Biotech Corp and Tango Therapeutics Inc

LEGNLegend Biotech Corp

TNGXTango Therapeutics Inc

LEGNLegend Biotech Corp

Market cap

$3.62B

P/E (TTM)

—

Forward P/E (NTM)

25.42x

Forward P/S (NTM)

2.17x

Rev growth (TTM)

59.6%

YTD performance

-13.4%

52W performance

-42.2%

FCF yield

-3.4%

TNGXTango Therapeutics Inc

Market cap

$3.87B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

121.5%

YTD performance

166.6%

52W performance

244.6%

FCF yield

-3.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

LEGN

TNGX

Detailed metrics comparison

LEGN

Legend Biotech Corp

TNGX

Tango Therapeutics Inc

Market Cap

LEGN$3.62B

TNGX$3.87B

Enterprise Value

LEGN$3.23B

TNGX$3.52B

Price

LEGN$18.62

TNGX$23.81

P/E Ratio

LEGNN/A

TNGXN/A

P/S Ratio

LEGN2.85x

TNGX71.83x

EV/Sales

LEGN2.54x

TNGX65.41x

EV/EBITDA

LEGN0.00x

TNGX0.00x

P/B Ratio

LEGN3.04x

TNGX3.82x

P/FCF Ratio

LEGNN/A

TNGXN/A

EV/FCF

LEGN-26.50x

TNGX-24.40x

PEG Ratio

LEGNN/A

TNGXN/A

Forward P/E (NTM)

LEGN25.42x

TNGXN/A

Forward P/S (NTM)

LEGN2.17x

TNGXN/A

Revenue (TTM)

LEGN$1.27B

TNGX$54M

Revenue Growth (YoY)

LEGN59.6%

TNGX121.5%

Forward Rev Growth

LEGN25.0%

TNGX732.8%

Gross Margin (TTM)

LEGN56.6%

TNGX0.0%

Operating Margin (TTM)

LEGN0.0%

TNGX0.0%

EBITDA Margin (TTM)

LEGN-0.8%

TNGX-249.8%

Net Margin (TTM)

LEGN-7.2%

TNGX-229.9%

FCF Margin (TTM)

LEGN-9.6%

TNGX-268.1%

Net Income (TTM)

LEGN$-92M

TNGX$-124M

FCF (TTM)

LEGN$-122M

TNGX$-144M

EPS (TTM)

LEGN-$0.47

TNGX-$0.83

ROE (TTM)

LEGN-870.0%

TNGX-2574.0%

ROA (TTM)

LEGN-539.0%

TNGX-2336.0%

ROIC (TTM)

LEGN-643.0%

TNGX-2574.0%

Cash

LEGN$673M

TNGX$346M

Debt

LEGN$278M

TNGX$0

Net Cash/Debt

LEGN$395M

TNGX$346M

Current Ratio (TTM)

LEGN3.04x

TNGX50.82x

Quick Ratio (TTM)

LEGN2.89x

TNGX49.95x

Debt/Equity (TTM)

LEGN0.23x

TNGX0.00x

Debt/Assets (TTM)

LEGN0.0%

TNGX0.0%

Interest Coverage (TTM)

LEGNN/A

TNGXN/A

Net Debt/EBITDA (TTM)

LEGN0.00x

TNGX0.00x

Beta

LEGN0.57

TNGX1.18

52W Performance

LEGN-42.2%

TNGX244.6%

YTD Performance

LEGN-13.4%

TNGX166.6%

% from 52W High

LEGN-50.3%

TNGX-30.8%

% from 52W Low

LEGN14.7%

TNGX255.9%

Asset Turnover (TTM)

LEGN0.75x

TNGX0.26x

FCF Yield (TTM)

LEGN-3.4%

TNGX-3.7%

Earnings Yield (TTM)

LEGN-2.5%

TNGX-3.2%

Dividend Yield (TTM)

LEGNN/A

TNGXN/A

Rule of 40

LEGN50.0

TNGX-146.6

EV/GP/RG

LEGN0.13

TNGXN/A

Ticker research

View LEGN research View TNGX research

Metric	LEGN Legend Biotech Corp	TNGX Tango Therapeutics Inc
Market & Valuation
Market Cap	$3.62B	$3.87B
Enterprise Value	$3.23B	$3.52B
Price	$18.62	$23.81
P/E Ratio	N/A	N/A
P/S Ratio	2.85x	71.83x
EV/Sales	2.54x	65.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.04x	3.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-26.50x	-24.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	25.42x	N/A
Forward P/S (NTM)	2.17x	N/A
Revenue & Growth
Revenue (TTM)	$1.27B	$54M
Revenue Growth (YoY)	59.6%	121.5%
Forward Rev Growth	25.0%	732.8%
Profitability
Gross Margin (TTM)	56.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.8%	-249.8%
Net Margin (TTM)	-7.2%	-229.9%
FCF Margin (TTM)	-9.6%	-268.1%
Net Income (TTM)	$-92M	$-124M
FCF (TTM)	$-122M	$-144M
EPS (TTM)	-$0.47	-$0.83
ROE (TTM)	-870.0%	-2574.0%
ROA (TTM)	-539.0%	-2336.0%
ROIC (TTM)	-643.0%	-2574.0%
Financial Health
Cash	$673M	$346M
Debt	$278M	$0
Net Cash/Debt	$395M	$346M
Current Ratio (TTM)	3.04x	50.82x
Quick Ratio (TTM)	2.89x	49.95x
Debt/Equity (TTM)	0.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	1.18
52W Performance	-42.2%	244.6%
YTD Performance	-13.4%	166.6%
% from 52W High	-50.3%	-30.8%
% from 52W Low	14.7%	255.9%
Efficiency & Yields
Asset Turnover (TTM)	0.75x	0.26x
FCF Yield (TTM)	-3.4%	-3.7%
Earnings Yield (TTM)	-2.5%	-3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	50.0	-146.6
EV/GP/RG	0.13	N/A
Ticker research	View LEGN research	View TNGX research

Valuation

P/S Ratio

LEGN

2.85x

TNGX

71.83x

EV/FCF

LEGN

-26.50x

TNGX

-24.40x

Growth & revenue

Revenue Growth TTM

TNGX

121.5%

LEGN

59.6%

Forward Revenue Growth

TNGX

732.8%

LEGN

25.0%

Profitability & performance

Gross Margin

LEGN

56.6%

TNGX

0.0%

ROE

LEGN

-870.0%

TNGX

-2574.0%

FCF Yield %

LEGN

-3.4%

TNGX

-3.7%

52-Week Performance

TNGX

244.6%

LEGN

-42.2%

Detailed metrics comparison

LEGN

Legend Biotech Corp

TNGX

Tango Therapeutics Inc

Market Cap

LEGN$3.62B

TNGX$3.87B

Enterprise Value

LEGN$3.23B

TNGX$3.52B

Price

LEGN$18.62

TNGX$23.81

P/E Ratio

LEGNN/A

TNGXN/A

P/S Ratio

LEGN2.85x

TNGX71.83x

EV/Sales

LEGN2.54x

TNGX65.41x

EV/EBITDA

LEGN0.00x

TNGX0.00x

P/B Ratio

LEGN3.04x

TNGX3.82x

P/FCF Ratio

LEGNN/A

TNGXN/A

EV/FCF

LEGN-26.50x

TNGX-24.40x

PEG Ratio

LEGNN/A

TNGXN/A

Forward P/E (NTM)

LEGN25.42x

TNGXN/A

Forward P/S (NTM)

LEGN2.17x

TNGXN/A

Revenue (TTM)

LEGN$1.27B

TNGX$54M

Revenue Growth (YoY)

LEGN59.6%

TNGX121.5%

Forward Rev Growth

LEGN25.0%

TNGX732.8%

Gross Margin (TTM)

LEGN56.6%

TNGX0.0%

Operating Margin (TTM)

LEGN0.0%

TNGX0.0%

EBITDA Margin (TTM)

LEGN-0.8%

TNGX-249.8%

Net Margin (TTM)

LEGN-7.2%

TNGX-229.9%

FCF Margin (TTM)

LEGN-9.6%

TNGX-268.1%

Net Income (TTM)

LEGN$-92M

TNGX$-124M

FCF (TTM)

LEGN$-122M

TNGX$-144M

EPS (TTM)

LEGN-$0.47

TNGX-$0.83

ROE (TTM)

LEGN-870.0%

TNGX-2574.0%

ROA (TTM)

LEGN-539.0%

TNGX-2336.0%

ROIC (TTM)

LEGN-643.0%

TNGX-2574.0%

Cash

LEGN$673M

TNGX$346M

Debt

LEGN$278M

TNGX$0

Net Cash/Debt

LEGN$395M

TNGX$346M

Current Ratio (TTM)

LEGN3.04x

TNGX50.82x

Quick Ratio (TTM)

LEGN2.89x

TNGX49.95x

Debt/Equity (TTM)

LEGN0.23x

TNGX0.00x

Debt/Assets (TTM)

LEGN0.0%

TNGX0.0%

Interest Coverage (TTM)

LEGNN/A

TNGXN/A

Net Debt/EBITDA (TTM)

LEGN0.00x

TNGX0.00x

Beta

LEGN0.57

TNGX1.18

52W Performance

LEGN-42.2%

TNGX244.6%

YTD Performance

LEGN-13.4%

TNGX166.6%

% from 52W High

LEGN-50.3%

TNGX-30.8%

% from 52W Low

LEGN14.7%

TNGX255.9%

Asset Turnover (TTM)

LEGN0.75x

TNGX0.26x

FCF Yield (TTM)

LEGN-3.4%

TNGX-3.7%

Earnings Yield (TTM)

LEGN-2.5%

TNGX-3.2%

Dividend Yield (TTM)

LEGNN/A

TNGXN/A

Rule of 40

LEGN50.0

TNGX-146.6

EV/GP/RG

LEGN0.13

TNGXN/A

Ticker research

View LEGN research View TNGX research

Metric	LEGN Legend Biotech Corp	TNGX Tango Therapeutics Inc
Market & Valuation
Market Cap	$3.62B	$3.87B
Enterprise Value	$3.23B	$3.52B
Price	$18.62	$23.81
P/E Ratio	N/A	N/A
P/S Ratio	2.85x	71.83x
EV/Sales	2.54x	65.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.04x	3.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-26.50x	-24.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	25.42x	N/A
Forward P/S (NTM)	2.17x	N/A
Revenue & Growth
Revenue (TTM)	$1.27B	$54M
Revenue Growth (YoY)	59.6%	121.5%
Forward Rev Growth	25.0%	732.8%
Profitability
Gross Margin (TTM)	56.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-0.8%	-249.8%
Net Margin (TTM)	-7.2%	-229.9%
FCF Margin (TTM)	-9.6%	-268.1%
Net Income (TTM)	$-92M	$-124M
FCF (TTM)	$-122M	$-144M
EPS (TTM)	-$0.47	-$0.83
ROE (TTM)	-870.0%	-2574.0%
ROA (TTM)	-539.0%	-2336.0%
ROIC (TTM)	-643.0%	-2574.0%
Financial Health
Cash	$673M	$346M
Debt	$278M	$0
Net Cash/Debt	$395M	$346M
Current Ratio (TTM)	3.04x	50.82x
Quick Ratio (TTM)	2.89x	49.95x
Debt/Equity (TTM)	0.23x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	1.18
52W Performance	-42.2%	244.6%
YTD Performance	-13.4%	166.6%
% from 52W High	-50.3%	-30.8%
% from 52W Low	14.7%	255.9%
Efficiency & Yields
Asset Turnover (TTM)	0.75x	0.26x
FCF Yield (TTM)	-3.4%	-3.7%
Earnings Yield (TTM)	-2.5%	-3.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	50.0	-146.6
EV/GP/RG	0.13	N/A
Ticker research	View LEGN research	View TNGX research